IART – Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings CIART
$11.73Name : Integra LifeSciences Holdings C
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $913,893,568.00
EPSttm : -6.47
Integra LifeSciences Holdings C
$11.73
0.17%$0.02Float Short %
10.47
Margin Of Safety %
Put/Call OI Ratio
0.17
EPS Next Q Diff
-0.05
EPS Last/This Y
2.29
EPS This/Next Y
0.17
Price
11.73
Target Price
15.5
Analyst Recom
3.09
Performance Q
-20.15
Relative Volume
0.8
Beta
1.07
Ticker: IART
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-10-20 | IART | 15.69 | 0.12 | 1.60 | 656 |
| 2025-10-21 | IART | 15.88 | 0.13 | 0.00 | 666 |
| 2025-10-22 | IART | 15.45 | 0.13 | 0.00 | 669 |
| 2025-10-23 | IART | 15.89 | 0.13 | 0.50 | 674 |
| 2025-10-24 | IART | 16.12 | 0.13 | 0.67 | 676 |
| 2025-10-27 | IART | 15.89 | 0.14 | 2.50 | 679 |
| 2025-10-28 | IART | 15.54 | 0.15 | 0.00 | 690 |
| 2025-10-29 | IART | 15.39 | 0.15 | 0.22 | 692 |
| 2025-10-30 | IART | 11.8 | 0.17 | 0.43 | 716 |
| 2025-10-31 | IART | 12.02 | 0.17 | 0.10 | 833 |
| 2025-11-03 | IART | 11.5 | 0.17 | 3.00 | 847 |
| 2025-11-04 | IART | 11.32 | 0.19 | 0.15 | 860 |
| 2025-11-05 | IART | 11.39 | 0.19 | 0.00 | 861 |
| 2025-11-06 | IART | 11.21 | 0.17 | 0.04 | 979 |
| 2025-11-07 | IART | 12.03 | 0.16 | 0.57 | 1029 |
| 2025-11-10 | IART | 12.18 | 0.17 | 999.99 | 1049 |
| 2025-11-11 | IART | 12.34 | 0.17 | 0.00 | 1051 |
| 2025-11-12 | IART | 12.09 | 0.17 | 1.00 | 1051 |
| 2025-11-13 | IART | 12.02 | 0.17 | 0.11 | 1051 |
| 2025-11-14 | IART | 11.77 | 0.17 | 999.99 | 1055 |
| 2025-11-17 | IART | 11.73 | 0.17 | 0.33 | 1054 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-10-20 | IART | 15.69 | 6.1 | - | 2.21 |
| 2025-10-21 | IART | 15.87 | 6.1 | - | 2.21 |
| 2025-10-22 | IART | 15.46 | 6.1 | - | 2.21 |
| 2025-10-23 | IART | 15.89 | 6.1 | - | 2.21 |
| 2025-10-24 | IART | 16.12 | 6.1 | - | 2.21 |
| 2025-10-27 | IART | 15.94 | 6.1 | - | 2.21 |
| 2025-10-28 | IART | 15.56 | 6.1 | - | 2.21 |
| 2025-10-29 | IART | 15.40 | 6.1 | - | 2.21 |
| 2025-10-30 | IART | 11.81 | 6.1 | - | 2.21 |
| 2025-10-31 | IART | 12.01 | 6.1 | - | 2.21 |
| 2025-11-03 | IART | 11.48 | -18.0 | - | 2.20 |
| 2025-11-04 | IART | 11.30 | -18.0 | - | 2.20 |
| 2025-11-05 | IART | 11.39 | -18.0 | - | 2.20 |
| 2025-11-06 | IART | 11.22 | -18.0 | - | 2.20 |
| 2025-11-07 | IART | 12.04 | -17.5 | - | 2.20 |
| 2025-11-10 | IART | 12.18 | -17.5 | - | 2.20 |
| 2025-11-11 | IART | 12.33 | -17.5 | - | 2.20 |
| 2025-11-12 | IART | 12.09 | -17.5 | - | 2.20 |
| 2025-11-13 | IART | 12.02 | -17.5 | - | 2.20 |
| 2025-11-14 | IART | 11.77 | -17.5 | - | 2.20 |
| 2025-11-17 | IART | 11.73 | -17.5 | - | 2.20 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-10-20 | IART | 0.00 | -5.30 | 9.48 |
| 2025-10-21 | IART | 0.00 | -5.30 | 9.48 |
| 2025-10-22 | IART | 0.00 | -5.30 | 9.48 |
| 2025-10-23 | IART | 0.00 | -5.30 | 9.48 |
| 2025-10-24 | IART | 0.00 | -5.30 | 9.48 |
| 2025-10-27 | IART | 0.00 | -4.95 | 10.17 |
| 2025-10-28 | IART | 0.00 | -4.95 | 10.17 |
| 2025-10-29 | IART | 0.00 | -4.95 | 10.17 |
| 2025-10-30 | IART | 0.00 | -4.95 | 10.17 |
| 2025-10-31 | IART | 0.00 | -4.95 | 10.17 |
| 2025-11-03 | IART | 0.00 | -5.26 | 10.17 |
| 2025-11-04 | IART | 0.00 | -5.26 | 10.17 |
| 2025-11-05 | IART | 0.00 | -5.26 | 10.17 |
| 2025-11-06 | IART | 0.07 | -5.26 | 10.17 |
| 2025-11-07 | IART | 0.07 | -5.26 | 10.17 |
| 2025-11-10 | IART | 0.07 | -5.24 | 10.17 |
| 2025-11-11 | IART | 0.07 | -5.24 | 10.17 |
| 2025-11-12 | IART | 0.07 | -5.24 | 10.48 |
| 2025-11-13 | IART | 0.07 | -5.24 | 10.48 |
| 2025-11-14 | IART | 0.07 | -5.24 | 10.47 |
| 2025-11-17 | IART | 0.07 | -1.20 | 10.47 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.54
Avg. EPS Est. Current Quarter
0.8
Avg. EPS Est. Next Quarter
0.49
Insider Transactions
0.07
Institutional Transactions
-1.2
Beta
1.07
Average Sales Estimate Current Quarter
432
Average Sales Estimate Next Quarter
392
Fair Value
Quality Score
35
Growth Score
36
Sentiment Score
16
Actual DrawDown %
84.8
Max Drawdown 5-Year %
-85.5
Target Price
15.5
P/E
Forward P/E
4.98
PEG
P/S
0.56
P/B
0.88
P/Free Cash Flow
EPS
-6.46
Average EPS Est. Cur. Y
2.2
EPS Next Y. (Est.)
2.37
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-30.15
Relative Volume
0.8
Return on Equity vs Sector %
-74.7
Return on Equity vs Industry %
-65.7
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
Integra LifeSciences Holdings CSector: Healthcare
Industry: Medical Devices
Employees: 4396
Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company addresses the needs of plastic, and reconstructive and general surgeons focused on the treatment of acute wounds, such as burns and chronic wounds, including diabetic foot ulcers; and provides surgical tissue repair products for hernia, tendon, peripheral nerve repair, and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. Further, it is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
stock quote shares IART – Integra LifeSciences Holdings Corporation Stock Price stock today
news today IART – Integra LifeSciences Holdings Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch IART – Integra LifeSciences Holdings Corporation yahoo finance google finance
stock history IART – Integra LifeSciences Holdings Corporation invest stock market
stock prices IART premarket after hours
ticker IART fair value insiders trading